Moleculin Biotech (MBRX) Other financing activities (2016 - 2026)
Moleculin Biotech (MBRX) posted quarterly Other financing activities of $406000.0 for Q4 2025, up 40500.0% year-over-year from N/an in Q4 2024, and down 63.46% quarter-over-quarter from $1.1 million in Q3 2025.
Moleculin Biotech (MBRX) Other financing activities (2016 - 2026) Analysis & Trends
Moleculin Biotech's Other financing activities history runs 8 years deep, the most recent figure standing at $406000.0 for Q4 2025.
- In Q4 2025, Other financing activities rose 40500.0% year-over-year to $406000.0; the TTM figure through Dec 2025 stood at $19.3 million (up 1932000.0% YoY), while the FY2025 annual figure was $1.5 million, up 152600.0% from the prior year.
- Other financing activities for Q4 2025 stood at $406000.0, down from $1.1 million in the prior quarter.
- The five-year high for Other financing activities was $17.8 million in Q2 2025, with the low at $1000.0 in Q4 2024.
- The 3-year median for Other financing activities is $234500.0 (2021), against an average of $3.2 million.
- Peak annual rise in Other financing activities reached 40500.0% in 2025, while the deepest fall reached 40500.0% in 2025.
- Moleculin Biotech's Other financing activities stood at $63000.0 in 2021, then plunged by 98.41% to $1000.0 in 2024, then jumped by 40500.0% to $406000.0 in 2025.
- Business Quant data shows MBRX's Other financing activities at $406000.0 in Q4 2025, $1.1 million in Q3 2025, and $17.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Moleculin Biotech | 3.35 Mn | 3.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Mn |
| Jun 30, 2026 | 2.80 Mn |
| Dec 31, 2025 | 406,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Sep 30, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Dec 31, 2019 | -1.55 Mn |
| Dec 31, 2019 | -1.55 Mn |
| Jun 30, 2019 | 1.55 Mn |
| Jun 30, 2019 | 1.55 Mn |